News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Can-Fite BioPharma Shifts Drug Manufacturing to China



1/22/2013 11:06:01 AM

by Richard Daverman, PhD

January 21, 2013 -- Can-Fite Biopharma, an Israeli firm developing drugs for inflammatory and liver disease, will transfer its drug production to China. The company said China’s Chemspec has optimized production of its APIs, reducing its costs considerably. Can-Fite is facing multiple Phase III clinical trials for its drug candidates, and it estimates that outsourcing the manufacturing to Chemspec will save the company millions of dollars. More details....

Stock Symbols: (TASE: CFBI; OTCBB: CANFY)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES